BB-rel@ldeleger:BB-rel-23895665 / 164-537 JSONTXT

{"project":"bionlp-ost-19-BB-rel-test","denotations":[{"id":"T2","span":{"begin":0,"end":373},"obj":"Paragraph"},{"id":"T9","span":{"begin":100,"end":114},"obj":"Phenotype"},{"id":"T10","span":{"begin":170,"end":182},"obj":"Geographical"},{"id":"T11","span":{"begin":194,"end":197},"obj":"Microorganism"},{"id":"T12","span":{"begin":272,"end":284},"obj":"Habitat"},{"id":"T13","span":{"begin":309,"end":324},"obj":"Phenotype"}],"text":"The World Health Organization has endorsed the use of molecular methods for the detection of TB and drug-resistant TB as a rapid alternative to culture-based systems. In South Africa, the Xpert MTB/Rif assay and the GenoType MTBDRplus have been implemented into reference laboratories for diagnosis of TB and drug-resistance, but their costs have not been fully elucidated."}